Massive database of compounds unveiled; Connectathon links EDC and EHR;

> ChEMBLdb, an online database that catalogs properties and activities of a half-million drugs and small molecules, launches this week thanks to Wellcome Trust funding of the European Bioinformatics Institute Announcement

> Nextrials participated in last week's Integrating the Healthcare Enterprise (IHE) Connectathon by linking its Prism EDC solution with electronic health record platforms. Release

> Open-source bio-data-sharing proponent Sage Bionetworks is partnering with Pfizer to build computational models in network biology. Item

> Oracle has taken the wraps off of Clinical Development Analytics, built on the software giant's Business Intelligence Suite Enterprise Edition Plus, which provides near real-time data across clinical development and includes links to pre- and post-marketing surveillance and healthcare apps. Announcement

> Symyx has released two solutions for its ISIS cheminformatics software: Isentris Forms, for a low-cost introduction to Isentris without full-scale deployment, and Isentris Data Miner, a phased migration path to Isentris for ISIS customers. Announcement

> Cell-IQ, an automated live cell observation and analysis system, is now available in the U.S. Release

> EDC solution provider DSG says it has teamed with a leading-edge pharmaceutical technology company on trials for early detection of Alzheimer's, Parkinson's, and Diabetes. Release

> InfoQuant, a maker of DNA copy number analysis software, has joined the BioIT Alliance. Announcement

> Metabolon has been awarded a patent--its sixth--for methods of discovery, disease treatment and diagnosis in metabolomics. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.